Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Klin Padiatr
; 226(6-7): 338-43, 2014 Nov.
Article
in En
| MEDLINE
| ID: mdl-25431866
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chromosomes, Human, Pair 21
/
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Gene Amplification
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Klin Padiatr
Year:
2014
Document type:
Article
Affiliation country:
Austria
Country of publication:
Alemania